Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML. N Engl J Med. 2018 Jun 21; 378(25):2386-2398.
View in:
PubMed
subject areas
Administration, Oral
Adolescent
Adult
Aged
Aged, 80 and over
Cell Count
Dose-Response Relationship, Drug
Drug Resistance, Neoplasm
Enzyme Inhibitors
Female
Follow-Up Studies
Glycine
Hemoglobins
Humans
Isocitrate Dehydrogenase
Leukemia, Myeloid, Acute
Male
Middle Aged
Mutation
Pyridines
Recurrence
Remission Induction
Survival Rate
Young Adult
authors with profiles
Robert K. Stuart